hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells

Published:2025-06 Issue:2 Volume:33 Page:200982
ISSN:2950-3299
Container-title:Molecular Therapy Oncology
language:en
Short-container-title:Molecular Therapy Oncology

Author:

Dutta Apratim,Chakraborty Sourio,Bhattacharya Apoorva,Basak Udit,Pati Subhadip,Mukherjee Sumon,Guha Deblina,Banerjee Shruti,Chaudhuri Nibedita Ray,Sarkar Diptendra,Jana Kuladip,Sa Gaurisankar,Dastidar Shubhra Ghosh,Das Tanya^ORCID

Funder

Department of Science and Technology, Ministry of Science and Technology, India

Irish Endocrine Society

Indian Council of Medical Research

Council of Scientific and Industrial Research, India

University Grants Commission

Bose Institute

Department of Biotechnology, Ministry of Science and Technology, India

Science and Engineering Research Board

Publisher

Elsevier BV

Reference82 articles.

1. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Natl. Acad. Sci. USA,2003

2. Cancer stem cells;Yu;Int. J. Biochem. Cell Biol.,2012

3. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment;Phi;Stem Cells Int.,2018

4. EMT, CTCs and CSCs in tumor relapse and drug-resistance;Mitra;Oncotarget,2015

5. Stemness-Related Markers in Cancer;Zhao;Cancer Transl. Med.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP